Seed projects, posters represent a wide range of labs working on technologies, therapeutic strategies, and fundamental research to advance understanding of age-related neurodegenerative disease

An advanced closed-loop anesthesia delivery system that monitors brain state to tailor propofol dose and achieve exactly the desired level of unconsciousness could reduce post-op side effects

Society for Neuroscience Award recognizes Professor Mark Bear’s synaptic plasticity research, its translation to potential amblyopia and autism treatments, and his career of mentorship.

A flexible new tool both monitors and manipulates neural activity in the brains of large animals.

Five MIT faculty, along with seven additional affiliates, are honored for outstanding contributions to medical research.

By analyzing epigenomic and gene expression changes that occur in Alzheimer’s disease, researchers identify cellular pathways that could become new drug targets

Scientists have invested decades in piecing together how our vision is so good at recognizing what’s familiar. A new study overcomes an apparent discrepancy in data to reveal a new insight into how it works.

In C. elegans worms, a single neuron named HSN uses multiple chemicals and connections to orchestrate egg-laying and locomotion over the course of several minutes

Neurons stochastically generated up to eight different versions of a protein regulating neurotransmitter release, which could vary how they communicate with other cells

Neurotypical humans readily optimize performance in ‘reversal learning’ games, but while mice learn the winning strategy, they refuse to commit to it, a new study shows. The research provides a mathematical way to track the rodents’ more mixed tactics

Neural activity during sleep has a signature structure that the brain uses to make profound improvements in our thinking and wellness

A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons and improving cognition in preclinical tests